跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEVETIRACETAM-AFT levetiracetam 500 mg/5 mL concentrate solution for infusion vial - TGA Drug Approval Details
Approvals
/
TGA
/
LEVETIRACETAM-AFT levetiracetam 500 mg/5 mL concentrate solution for infusion vial
Approved
STANDARD
LEVETIRACETAM-AFT levetiracetam 500 mg/5 mL concentrate solution for infusion vial
AFT Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
8a6f52e0567763ce
Company
AFT Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
8a6f52e0567763ce
Product Name
LEVETIRACETAM-AFT levetiracetam 500 mg/5 mL concentrate solution for infusion vial
Artg Id
218280
Artg Name
LEVETIRACETAM-AFT levetiracetam 500 mg/5 mL concentrate solution for infusion vial
Sponsor
AFT Pharmaceuticals Pty Ltd
Company Detail Path
/organization/aft-pharmaceuticals-au-pty-ltd
Artg Date
2014-11-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/9294c9a7f48064303f7dab1aad363f37.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/a9be9997f5a482fe6837efc8414f2c43.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
8a6f52e0567763ce
Type
Standard
Back to TGA Approvals